Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Behavioural weight loss treatment preferences of college students with overweight and obesity.

Bihuniak JD, Bryant T, Kleiman J, Rotondo M, Decoteau J, Haisley S, Monserrate D, Cunningham M, MacKenzie A, Dauz S, Ippolito R, Fernandes N, LaRose JG, Leahey TM.

Clin Obes. 2020 Feb;10(1):e12343. doi: 10.1111/cob.12343. Epub 2019 Oct 15.

PMID:
31613059
2.

Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping.

Baniak N, Gilks CB, DeCoteau J, Kinloch M.

Int J Gynecol Pathol. 2019 Sep 27. doi: 10.1097/PGP.0000000000000638. [Epub ahead of print]

PMID:
31569187
3.

A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51.

Pastushok L, Fu Y, Lin L, Luo Y, DeCoteau JF, Lee K, Geyer CR.

Sci Rep. 2019 Aug 2;9(1):11227. doi: 10.1038/s41598-019-47600-y.

4.

Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs.

Barreto K, Maruthachalam BV, Hill W, Hogan D, Sutherland AR, Kusalik A, Fonge H, DeCoteau JF, Geyer CR.

Nucleic Acids Res. 2019 May 21;47(9):e50. doi: 10.1093/nar/gkz131.

5.

Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon.

Baniak N, Fadare O, Köbel M, DeCoteau J, Parkash V, Hecht JL, Hanley KZ, Gwin K, Zheng W, Quick CM, Jarboe EA, Liang SX, Kinloch M.

Am J Surg Pathol. 2019 Apr;43(4):531-537. doi: 10.1097/PAS.0000000000001209.

PMID:
30585826
6.

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Toosi BM, El Zawily A, Truitt L, Shannon M, Allonby O, Babu M, DeCoteau J, Mousseau D, Ali M, Freywald T, Gall A, Vizeacoumar FS, Kirzinger MW, Geyer CR, Anderson DH, Kim T, Welm AL, Siegel P, Vizeacoumar FJ, Kusalik A, Freywald A.

Oncogene. 2018 Jul;37(30):4073-4093. doi: 10.1038/s41388-018-0228-x. Epub 2018 Apr 27.

7.

89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I.

Chekol R, Solomon VR, Alizadeh E, Bernhard W, Fisher D, Hill W, Barreto K, DeCoteau JF, Parada AC, Geyer CR, Fonge H.

Oncotarget. 2018 Mar 30;9(24):17117-17132. doi: 10.18632/oncotarget.24965. eCollection 2018 Mar 30.

8.

RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance.

Alam MK, Alhhazmi A, DeCoteau JF, Luo Y, Geyer CR.

Cell Chem Biol. 2016 Mar 17;23(3):381-91. doi: 10.1016/j.chembiol.2016.02.010.

9.

Quantitative and multiplexed DNA methylation analysis using long-read single-molecule real-time bisulfite sequencing (SMRT-BS).

Yang Y, Sebra R, Pullman BS, Qiao W, Peter I, Desnick RJ, Geyer CR, DeCoteau JF, Scott SA.

BMC Genomics. 2015 May 6;16:350. doi: 10.1186/s12864-015-1572-7.

10.
11.

Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.

Allonby O, El Zawily AM, Freywald T, Mousseau DD, Chlan J, Anderson D, Benmerah A, Sidhu V, Babu M, DeCoteau J, Freywald A.

Cell Signal. 2014 Dec;26(12):2645-57. doi: 10.1016/j.cellsig.2014.08.007. Epub 2014 Aug 23.

PMID:
25152371
12.

Allosteric lariat peptide inhibitors of Abl kinase.

Bharathikumar VM, Barreto K, Decoteau JF, Geyer CR.

Chembiochem. 2013 Nov 4;14(16):2119-25. doi: 10.1002/cbic.201300253. Epub 2013 Sep 12.

PMID:
24030821
13.

Yeast two-hybrid screening of cyclic peptide libraries using a combination of random and PI-deconvolution pooling strategies.

Barreto K, Aparicio A, Bharathikumar VM, DeCoteau JF, Geyer CR.

Protein Eng Des Sel. 2012 Sep;25(9):453-64. doi: 10.1093/protein/gzs029. Epub 2012 Jul 4.

PMID:
22763264
14.

The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.

Truitt L, Freywald T, DeCoteau J, Sharfe N, Freywald A.

Cancer Res. 2010 Feb 1;70(3):1141-53. doi: 10.1158/0008-5472.CAN-09-1710. Epub 2010 Jan 19.

15.

A genetic screen for isolating "lariat" Peptide inhibitors of protein function.

Barreto K, Bharathikumar VM, Ricardo A, DeCoteau JF, Luo Y, Geyer CR.

Chem Biol. 2009 Nov 25;16(11):1148-57. doi: 10.1016/j.chembiol.2009.10.012.

16.

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.

Lakshmikuttyamma A, Scott SA, DeCoteau JF, Geyer CR.

Oncogene. 2010 Jan 28;29(4):576-88. doi: 10.1038/onc.2009.361. Epub 2009 Nov 2.

PMID:
19881540
17.

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.

Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, Casson AG.

Carcinogenesis. 2009 Dec;30(12):2117-22. doi: 10.1093/carcin/bgp254.

PMID:
19843644
18.

RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.

Lakshmikuttyamma A, Takahashi N, Pastural E, Torlakovic E, Amin HM, Garcia-Manero G, Voralia M, Czader M, DeCoteau JF, Geyer CR.

J Hematol Oncol. 2009 Jul 14;2:28. doi: 10.1186/1756-8722-2-28.

19.

Cytogenetic abnormality 46,XX,add(21)(q11.2) in a patient with follicular dendritic cell sarcoma.

Suzuki N, Katsusihma H, Takeuchi K, Nakamura S, Ishizawa K, Ishii S, Moriya T, DeCoteau JF, Miura I, Ichinohasama R.

Cancer Genet Cytogenet. 2008 Oct;186(1):54-7. doi: 10.1016/j.cancergencyto.2008.06.002.

PMID:
18786443
20.

Fli-1 expression in malignant melanoma.

Torlakovic EE, Slipicevic A, Flørenes VA, Chibbar R, DeCoteau JF, Bilalovic N.

Histol Histopathol. 2008 Nov;23(11):1309-14. doi: 10.14670/HH-23.1309.

PMID:
18785112
21.

In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes.

Jiang G, Freywald T, Webster J, Kozan D, Geyer R, DeCoteau J, Narendran A, Freywald A.

Mol Cancer Res. 2008 Feb;6(2):291-305. doi: 10.1158/1541-7786.MCR-07-0047.

22.

Bcr-Abl induces autocrine IGF-1 signaling.

Lakshmikuttyamma A, Pastural E, Takahashi N, Sawada K, Sheridan DP, DeCoteau JF, Geyer CR.

Oncogene. 2008 Jun 19;27(27):3831-44. doi: 10.1038/onc.2008.8. Epub 2008 Feb 4.

PMID:
18246120
23.

N-myristoyltransferase: a potential novel diagnostic marker for colon cancer.

Shrivastav A, Varma S, Saxena A, DeCoteau J, Sharma RK.

J Transl Med. 2007 Nov 16;5:58.

24.

Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.

Scott SA, Lakshimikuttysamma A, Sheridan DP, Sanche SE, Geyer CR, DeCoteau JF.

Exp Hematol. 2007 Feb;35(2):263-73.

PMID:
17258075
25.

Pax-5 expression in nonhematopoietic tissues.

Torlakovic E, Slipicevic A, Robinson C, DeCoteau JF, Alfsen GC, Vyberg M, Chibbar R, Flørenes VA.

Am J Clin Pathol. 2006 Nov;126(5):798-804.

PMID:
17050077
26.

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines.

Pastural E, Takahashi N, Dong WF, Bainbridge M, Hull A, Pearson D, Huang S, Lowsky R, DeCoteau JF, Geyer CR.

Oncogene. 2007 Mar 8;26(11):1586-94. Epub 2006 Sep 4.

PMID:
16953217
27.

5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.

Scott SA, Dong WF, Ichinohasama R, Hirsch C, Sheridan D, Sanche SE, Geyer CR, Decoteau JF.

Leuk Res. 2006 Jan;30(1):69-76. Epub 2005 Jul 25.

PMID:
16043219
28.

Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy.

Takahashi N, Miura I, Kobayashi Y, Kume M, Yoshioka T, Otane W, Ohtsubo K, Takahashi K, Kitabayashi A, Kawabata Y, Hirokawa M, Nishijima H, Ichinohasama R, Decoteau J, Miura AB, Sawada K.

Int J Hematol. 2005 Apr;81(3):235-41.

PMID:
15814334
29.

Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.

Scott SA, Kimura T, Dong WF, Ichinohasama R, Bergen S, Kerviche A, Sheridan D, DeCoteau JF.

Leuk Res. 2004 Dec;28(12):1293-301.

PMID:
15475071
30.
31.
32.

T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction.

Willenbrock K, Ichinohasama R, Kadin ME, Miura I, Terui T, Meguro K, Fukuhara O, DeCoteau JF, Hansmann ML.

Lab Invest. 2002 Sep;82(9):1103-9.

33.

Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: potential role of cytokines in clinical manifestations.

Al-Hashmi I, Decoteau J, Gruss HJ, Zielenska M, Thorner P, Poon A, Reis M, Freedman M, Lorenzana A.

Leuk Lymphoma. 2001 Feb;40(5-6):599-611.

PMID:
11426532
34.

MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability.

Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott S, Henry M, Kadin ME, DeCoteau JF.

Blood. 2000 Mar 1;95(5):1767-72.

PMID:
10688836
35.

Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.

Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K.

Leukemia. 2000 Jan;14(1):169-82. Review.

36.

Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement.

Signoretti S, Murphy M, Puddu P, DeCoteau JF, Faraggiana T, Kadin ME, Loda M.

Diagn Mol Pathol. 1999 Dec;8(4):176-82.

PMID:
10617273
37.

Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature.

Al-Tweigeri T, Magliocco AM, DeCoteau JF.

Gynecol Oncol. 1999 Jan;72(1):120-2. Review.

PMID:
9889044
38.

Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature.

Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, Mori S, Kadin ME, Ooya K.

Am J Surg Pathol. 1998 Dec;22(12):1528-37. Review.

PMID:
9850179
39.

Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily.

Paulli M, Berti E, Boveri E, Kindl S, Bonoldi E, Gambini C, Rosso R, Borroni G, Straccapansa V, Magrini U, DeCoteau JE, Krammer PH, Möller P, Kadin ME.

Hum Pathol. 1998 Nov;29(11):1223-30.

PMID:
9824099
40.

A recurrent nonrandom translocation (3;7)(q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma.

Ichinohasama R, Miura I, Funato T, Sato I, Suzuki C, Saito Y, Decoteau JF, Myers JB, Kadin ME, Sawai T, Ooya K.

Cancer Genet Cytogenet. 1998 Jul 1;104(1):19-27.

PMID:
9648553
41.

Translocation (3;16)(q27;p11) in a patient with diffuse large B-cell lymphoma associated with the BCL-6 gene rearrangement.

Ichinohasama R, Miura I, Shishido T, Matsumoto K, Shimizu Y, Miki T, DeCoteau JF, Kadin ME, Ooya K.

Cancer Genet Cytogenet. 1998 Jun;103(2):133-9.

PMID:
9614912
42.

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1998 Jun;22(2):114-21.

PMID:
9598798
43.

A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation.

Ott G, Bastian BC, Katzenberger T, Decoteau JF, Kalla J, Rosenwald A, Weissinger F, Ott MM, Kadin ME, Müller-Hermelink HK.

Br J Haematol. 1998 Jan;100(1):187-90.

PMID:
9450809
44.
45.

Cloning, expression, and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene, hLim-1.

Dong WF, Heng HH, Lowsky R, Xu Y, DeCoteau JF, Shi XM, Tsui LC, Minden MD.

DNA Cell Biol. 1997 Jun;16(6):671-8.

PMID:
9212161
46.

Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.

DeCoteau JF, Knaus PI, Yankelev H, Reis MD, Lowsky R, Lodish HF, Kadin ME.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5877-81.

47.
48.

Peripheral CD4+ CD8- gammadelta T cell lymphoma: a case report with multiparameter analyses.

Ichinohasama R, Miura I, Takahashi T, Yaginuma Y, Myers J, DeCoteau JF, Yee C, Kadin ME, Mori S, Sawai T.

Hum Pathol. 1996 Dec;27(12):1370-7.

PMID:
8958314
49.

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.

Knaus PI, Lindemann D, DeCoteau JF, Perlman R, Yankelev H, Hille M, Kadin ME, Lodish HF.

Mol Cell Biol. 1996 Jul;16(7):3480-9.

Supplemental Content

Loading ...
Support Center